Related Experiment Video
Updated: Jul 14, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope
1Shandong Medicinal Biotechnology Center, Shandong Academy of Medical Science, Jinan, China.
Abstract:
A potentially powerful approach for in vivo gene delivery is to target retroviral vectors to specific cells through interactions between cell surface receptors and appropriately engineered viral envelope proteins, but this has so far met with little success. We report here an attempt to target ecotropic MLV retroviral vectors to human cells infected by hepatitis B virus (HBV) through the interaction between the HBV PreS1 domain and the receptors on the cell surface. We examined 7 MLV chimeric envelope derivatives that contained either the HBV PreS1 peptide or PreS1 aa 21-47 segment (partial PreS1, pPreS1), which was inserted at various locations within the SU of the MoMLV Env. In addition to infecting host NIH 3T3 cells, some of pseudotyped viruses could transduce human cells. Our results demonstrate that short peptide ligands inserted at appropriate locations in the MLV envelope can selectively target retroviruses to human cells.
More Related Videos
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
Retroviruses
Retrovirus Life Cycles
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Viruses with RNA Genomes
Inhibitors of Virion Maturation and Assembly